$SYNH · Syneos Health, Inc. Congress Trades

Rep. Josh Gottheimer (NJ-05) conducted extensive trading activity in January 2023 across a diversified portfolio of blue-chip and growth stocks, with most transactions valued between $1,001-$15,000. Notably, he also engaged in significant options trading on Microsoft (MSFT), selling and purchasing call options valued between $250,001-$1,000,000 with various strike prices and expiration dates.

Rep. Josh Gottheimer made 12 transactions in a Morgan Stanley Select UMA Account during December 2022, involving purchases and partial sales of pharmaceutical and healthcare stocks including Amgen, ADP, Blackstone, Eli Lilly, Fidelity National Information Services, HaloZyme, Insmed, Pharmaceutical GRP, Ritchie Bros., Shoals Technologies, Supernus Pharmaceuticals, and Syneos Health, with all transactions valued between $1,001-$15,000.

Rep. Josh Gottheimer (NJ-05) conducted 38 transactions in January 2022 through Morgan Stanley managed accounts, primarily buying and selling individual stocks in the $1,001-$15,000 range, with one notable exception: purchasing Microsoft call options (strike $145, expiring 9/16/2022) for $50,001-$100,000. The portfolio activity included positions in tech stocks (MSFT, NVDA, TSLA, ISRG, LRCX), financials (COF, FIS), consumer discretionary (KO, EL, BOOT), and international ADRs.

Rep. Josh Gottheimer (NJ-05) conducted multiple stock and options transactions in August 2021, including purchases of AMD, BKNG, HALO, and TCEHY, sales of DAVA, NSC, PINS, SYNH, and W stocks, and significant Microsoft call options activity ranging from $500,001 to $5,000,000 across multiple strike prices and expiration dates.